Storia in 2 fonti

Here's The 'Cleanest Large-Cap Story In Medtech,' It's Up 5%

Edwards Lifesciences stock launched higher Friday after the medtech company beat Wall Street's top- and bottom-line expectations.

Raccontata da

investors.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo11 g fa

Here's The 'Cleanest Large-Cap Story In Medtech,' It's Up 5%

Edwards Lifesciences stock launched higher Friday after the medtech company beat Wall Street's top- and bottom-line expectations.

originale

benzinga.com10 g fa

Why Is Edwards Lifesciences Stock Gaining Friday? - Edwards Lifesciences (NYSE:EW)

Edwards beat Q2 ($1.741B, +13.6% YoY) on TAVR procedures ($1.3B, +11.3%); guidance raised. Double-digit procedural growth (TAVR/TMTT) signals sustained medtech disruption momentum—regulated-market innovation framework delivers.

Leggi questa versione → originale

Timeline cronologica

giovedì 23 luglio 2026·investors.com
Here's The 'Cleanest Large-Cap Story In Medtech,' It's Up 5%
Edwards Lifesciences stock launched higher Friday after the medtech company beat Wall Street's top- and bottom-line expectations.
venerdì 24 luglio 2026·benzinga.com
Why Is Edwards Lifesciences Stock Gaining Friday? - Edwards Lifesciences (NYSE:EW)
Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.